Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Can molgramostim enhance the antitumor effects of cytotoxic drugs in patients with advanced sarcomas?

April 26, 2017advanced antitumor cytotoxic drugs enhance Patients sarcomas

0

Posted

Can molgramostim enhance the antitumor effects of cytotoxic drugs in patients with advanced sarcomas?

1 Answer

0

Posted

A phase I study was designed for the amalgamation of two previously studied antisarcoma regimens (ifosfamide+doxorubicin and mitomycin+doxorubicin+cisplatin) supported by molgramostim. Thus, we hoped to develop a better regimen for the treatment of advanced sarcomas.